Cargando…
Residual OCTN2 transporter activity, carnitine levels and symptoms correlate in patients with primary carnitine deficiency
BACKGROUND: The prevalence of primary carnitine deficiency (PCD) in the Faroe Islands is the highest reported in the world (1:300). Serious symptoms related to PCD, e.g. sudden death, have previously only been associated to the c.95A > G/c.95A > G genotype in the Faroe Islands. We report and c...
Autores principales: | Rasmussen, Jan, Lund, Allan M., Risom, Lotte, Wibrand, Flemming, Gislason, Hannes, Nielsen, Olav W., Køber, Lars, Duno, Morten |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5121291/ https://www.ncbi.nlm.nih.gov/pubmed/27896095 http://dx.doi.org/10.1016/j.ymgmr.2014.04.008 |
Ejemplares similares
-
Cholesterol stimulates the cellular uptake of L-carnitine by the carnitine/organic cation transporter novel 2 (OCTN2)
por: Zhang, Lu, et al.
Publicado: (2021) -
Characterization of Exosomal SLC22A5 (OCTN2) carnitine transporter
por: Console, Lara, et al.
Publicado: (2018) -
Carnitine transporter OCTN2 and carnitine uptake in bovine kidney cells is regulated by peroxisome proliferator-activated receptor β/δ
por: Zhou, Xiaodan, et al.
Publicado: (2014) -
Functional genomics of OCTN2 variants informs protein-specific variant effect predictor for Carnitine Transporter Deficiency
por: Koleske, Megan L., et al.
Publicado: (2022) -
OCTN2-Mediated Acetyl-l-Carnitine Transport in Human Pulmonary Epithelial Cells In Vitro
por: Salomon, Johanna J., et al.
Publicado: (2019)